Tag: Prescription Drugs
2000 to 2011 Saw Shift in Treatment for Advanced NSCLC
Rise in use of pemetrexed, erlotinib, bevacizumab; longest treatment duration with these agents
Letrozole Tops Aspirin for Halting Ovarian Hyperstimulation
Decreases incidence of moderate and severe early-onset ovarian hyperstimulation syndrome
Sequential Empagliflozin, Linagliptin Diabetes Tx Effective
Glucose control most probably mediated by effects on alpha- and beta-cell function
Fenofibrate May Reduce CVD in Patients With DM, Dyslipidemia
No reduction in primary outcome for 4,644 ACCORD participants followed for median of 9.7 years
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Reduced all-cause death for chronic kidney disease, congestive heart failure, chronic liver disease
ACP Updates Recommendations for Oral Medications in T2DM
Recs serve as update to 2012 American College of Physicians guideline
Zoledronic Acid Every 12 Weeks Noninferior in Bone Metastases
No increase in risk of skeletal events versus treatment every four weeks for bone metastases
Ledipasvir-Sofosbuvir Effective for Chronic HCV in Adolescents
98 of 100 patients reached sustained virologic response at 12 weeks; no virologic failure observed
Burden of Anticholinergic Meds in Older Adults Must Be Considered
Often prescribed to older adults; measures developed for quantifying anticholinergic burden
Aflibercept Rescues Vision After Laser for Diabetic Macular Edema
Improves visual and anatomic outcomes among eyes experiencing visual loss after laser DME treatment
